U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907965) titled 'A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidn... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906743) titled 'Mandala Coloring in Late Pregnancy' on Oct. 26. Brief Summary: Anxiety, depression and poo... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907523) titled 'Topical Insulin Versus Irradiated Amniotic Fluid Gel for Wound Healing in Epidermolysis Bul... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07905989) titled 'Twelve Weeks Sofosbuvir/Daclatasvir in HCV Infected Children Aged 6-18 Years' on June 22. ... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906925) titled 'Effect of Temperature Elevation on the Antimicrobial Efficacy of Two Root Canal Irrigants i... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906041) titled 'Tirzepatide and Organ-specific Biological Aging' on Oct. 26. Brief Summary: The purpose of... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906314) titled 'Post-Market Registry Study for Vibrant Hearing Solutions' on Oct. 23. Brief Summary: This ... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07905950) titled 'Exploratory Study of Short-Course Radiotherapy Followed by Adebrelimab Combined With Chemot... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906639) titled 'A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis... Read More
U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906301) titled 'Organoid Drug Sensitivity-Guided Therapy for Refractory Tumors' on Oct. 24. Brief Summary:... Read More